Skip to Main Content

Paper Details

Eligibility for <sup>177</sup>Lu-PSMA Therapy Depends on the Choice of Companion Diagnostic Tracer: A Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>99m</sup>Tc-MIP-1404 in Metastatic Castration-Resistant Prostate Cancer.
J Nucl Med
5
2023
Author NameAffiliation
Amit BahlBristol Cancer Institute
  • 1 - 1

Datasets

Release 1.2